Preparing for a Successful Rare Disease Commercial Launch Through HCP Mapping and Virtual HCP Engagement

3 mins read
16 July 2026

Case Study (Belgium)

────────────────────────────────────────────────────────────

Executive Summary

Industry
Rare Disease Biotechnology

Challenge
Commercial launch preparation following reimbursement approval in Belgium.

Solution
Multilingual virtual engagement program mapping 1,500 HCPs and referral pathways by Inizio Engage Commercial Solutions.

Results
– 1,287 HCPs engaged
– Referral ecosystem mapped
– KOLs identified
– Launch-ready engagement strategy developed

────────────────────────────────────────────────────────────

In Detail

The Challenge

Understanding the Belgian referral landscape before commercial launch to enable targeted HCP engagement.

Commercial launch success in rare disease depends on identifying referral networks and engaging the right healthcare professionals before field deployment begins.

Following reimbursement approval in Belgium, our client needed actionable commercial intelligence to map referral pathways, identify high-potential HCPs and reduce launch risk.

The objective was to create a robust foundation for future commercial engagement and disease awareness activities across hospitals, specialist centers and private practices.

 

Our Approach

Designing a virtual HCP engagement program to generate the commercial intelligence needed for a successful rare disease launch.

Inizio Engage developed an outreach program to map the Belgian referral landscape, validate healthcare professional profiles and identify high-potential referral networks.

Over three months, our multilingual team engaged approximately 1,500 healthcare professionals, generating the market intelligence needed to inform future commercial engagement, disease awareness and launch planning.

 

 

What We Delivered

Transforming HCP engagement into actionable commercial intelligence.

A dedicated multilingual engagement team:

  • Targeted 1,500 healthcare professionals across Belgium
  • Mapped the Belgian rare disease referral ecosystem, including referral pathways
  • Validated HCP profiles and identification of market opportunities
  • Identified key opinion leaders (KOLs), local influencers and referral centers
  • Carried out disease awareness conversations to support earlier diagnosis and appropriate referral
  • Captured HCP consent for future scientific and commercial communications
  • Delivered weekly reporting and project governance

 

The Results

Creating a launch-ready commercial engagement strategy built on actionable HCP insights.

Within three months, Inizio Engage successfully engaged 1,287 healthcare professionals across Belgium, generating the commercial intelligence needed to support launch planning.

The project transformed a broad HCP database into a prioritized commercial engagement strategy, equipping the client with the insights needed to support commercial launch, disease awareness and future HCP and KOL engagement.

 

Why Inizio Engage Benelux

Inizio Engage partners with life sciences companies to provide local expertise, multilingual engagement and scalable commercial solutions from market preparation through to launch.

Our experienced commercial teams help clients identify the right healthcare professionals, generate actionable market intelligence and deploy field, hybrid and virtual engagement programs that create the foundations for long-term commercial success.